We at PressCise want to extend our warmest wishes to our friends near and far this holiday season. We wish you a festive and bright year-end surrounded by family, friends, and a exciting visions for the new year ahead.
Cheers to 2024!
November 13 - 16, 2023
MEDICA tradefair, Düsseldorf, Germany
PressCise CTO and Co-Inventor Josefin Damm and CEO, PhD. Andreas Nilsson attended the Medica 2023 trade fair alongside our WeroSwiss colleagues. It was a fantastic event with many great demonstrations and conversations. Thank you for helping us make it such a success!
PressCise has been acquired by Wernli AG!
It is with excitement that we announce this next chapter in PressCise's bright future! We welcome you to learn more about our new Wernli AG team by visiting them at: http://www.weroswiss.com
September 17-21, 2023
Miami Beach, Florida, USA
PressCise CTO and Co-Inventor Josefin Damm presented the abstract “Innovative Compression Technology May Reduce Hospital Visits and Improves Self-care in Venous Leg Ulcer Patients”, at UIP 2023 in Florida, USA.
The American Vein & Lymphatic Society together with the American Venous Forum, Canadian Society of Phlebology, and Mexican Academy of Phlebology & Lymphology organized this leading international medical conference devoted to venous and lymphatic medicine. It was a fantastic event full of many new and familiar faces!
May 3-5, 2023
EWMA and ICC Annual Meeting,
CEO, PhD Andreas Nilsson, CTO, Co-Inventor Josefin Damm and Professor, Inventor Torbjörn Lundh attended EWMA (European Wound Management Association) and the annual ICC meeting (International Compression Club).
Two presentations were held at the ICC meeting by PhD Nilsson and Prof. Lundh.
April 26-30, 2023
SAWC spring, National Harbor, MD, USA
PressCise, together with University of Gothenburg and Chalmers University of Technology, had no more than four accepted poster presentations at the Symposium on Advanced Wound Care.
Lundatex® bandages to Ukraine
As an act of support, we decided to donate 5 000 of our Lundatex® medical bandages to Ukraine. 🇺🇦 🇸🇪
Happy to announce another European patent approval!
The PressCise owned patent “A kit and therapeutic pressure assembly with patches for applying pressure to a limb or other body part” was approved by the European Patent Office (EPO).
The patent covers the products PressPatch™ and FixPatch™ which are part of the Lundatex® system – a compression product maintaining a low, safe resting pressure and a high effective working pressure.